Clinical Co-Management Arrangements: Trends, Issues and FMV ConsiderationsCBIZ, Inc.
Healthcare providers are under scrutiny and feel pressure from patients, employers, insurance and the federal and state governments to provide higher quality care at lower costs and higher efficiency.
Implementation of Responsible Supply Chain Management within the Healthcare S...Sherif Zaki Tehemar
Presentation that focuses on how to implement Responsible Supply Chain Management within the Corporate Social Responsibility Context in the Healthcare Sector. The presentation showed how Dr. Soliman Hospital in Jeddah implemented CSR and responsibility concept within its supply chain.
The Rise (or Fall?) of Pharmacy Management in the Technology AgeCompleteRx
Technology is a critical tool in providing quality, cost
effective healthcare. An overview of key technologies
which effect day to day pharmacy management will be
reviewed. Future market and technology trends which
could alter the professional landscape for pharmacy will
be discussed.
The Centers for Medicare and Medicaid (CMS) is planning to test bundled payments for hip and knee replacements, which will hold hospitals accountable for their costs and quality of care.
PYA Principal Martie Ross presented the keynote address, “The March to MIPS: The Merit-Based Payment System,” at the Kansas Medical Group Management Association 2016 Fall Conference, September 21-23, 2016, at the Overland Park Marriott in Overland Park, Kansas.
The presentation will include:
An introduction to the Medicare Merit-Based Incentive Payment System (MIPS).
A discussion of the four components of the MIPS composite score.
An exploration of the penalties and bonuses associated with the MIPS composite score, as well as the reputational impact of the publicly reported MIPS composite score.
ACO and Payer Partnership- Surviving Health Care ReformAllen Spath
Health care reform initiatives offered through an ACO entity creates opportunities for both providers and payers to deliver affordable and high quality care for consumers. Each partner comes to the table with valuable resources to achieve common goals and outcomes.
The Value of Improved Clinical Information Management for Payersibi
A solid strategy for managing clinical data offers providers a single, consistent, and accurate view of member care outside their practices. Payers can quickly identify gaps in care and alert providers to promote better outcomes. This new relationship paradigm, however, can only be successful if it is data-driven. View some possible enhancements.
Clinical Co-Management Arrangements: Trends, Issues and FMV ConsiderationsCBIZ, Inc.
Healthcare providers are under scrutiny and feel pressure from patients, employers, insurance and the federal and state governments to provide higher quality care at lower costs and higher efficiency.
Implementation of Responsible Supply Chain Management within the Healthcare S...Sherif Zaki Tehemar
Presentation that focuses on how to implement Responsible Supply Chain Management within the Corporate Social Responsibility Context in the Healthcare Sector. The presentation showed how Dr. Soliman Hospital in Jeddah implemented CSR and responsibility concept within its supply chain.
The Rise (or Fall?) of Pharmacy Management in the Technology AgeCompleteRx
Technology is a critical tool in providing quality, cost
effective healthcare. An overview of key technologies
which effect day to day pharmacy management will be
reviewed. Future market and technology trends which
could alter the professional landscape for pharmacy will
be discussed.
The Centers for Medicare and Medicaid (CMS) is planning to test bundled payments for hip and knee replacements, which will hold hospitals accountable for their costs and quality of care.
PYA Principal Martie Ross presented the keynote address, “The March to MIPS: The Merit-Based Payment System,” at the Kansas Medical Group Management Association 2016 Fall Conference, September 21-23, 2016, at the Overland Park Marriott in Overland Park, Kansas.
The presentation will include:
An introduction to the Medicare Merit-Based Incentive Payment System (MIPS).
A discussion of the four components of the MIPS composite score.
An exploration of the penalties and bonuses associated with the MIPS composite score, as well as the reputational impact of the publicly reported MIPS composite score.
ACO and Payer Partnership- Surviving Health Care ReformAllen Spath
Health care reform initiatives offered through an ACO entity creates opportunities for both providers and payers to deliver affordable and high quality care for consumers. Each partner comes to the table with valuable resources to achieve common goals and outcomes.
The Value of Improved Clinical Information Management for Payersibi
A solid strategy for managing clinical data offers providers a single, consistent, and accurate view of member care outside their practices. Payers can quickly identify gaps in care and alert providers to promote better outcomes. This new relationship paradigm, however, can only be successful if it is data-driven. View some possible enhancements.
Key Strategies for Compensating Physician Administrative PositionsMD Ranger, Inc.
Establishing rates for medical directorships has hidden challenges and risks. Even the most sophisticated market data benchmarks should be thoroughly examined and utilized properly. In addition to analyzing market data correctly, there’s an art to establishing rates policies for your organization. This webinar addresses challenges to determining appropriate rates and shares successful organizational policies.
Three Keys to a Successful Margin: Charges, Costs, and LaborHealth Catalyst
How can cost management and complete charge capture protect and enhance the margin?
In this webinar, we will look at 2024 margin pressures likely to impact your organization’s financial resiliency. This presentation will also share how organizations can move from Fee-for-Service to Value; bringing Cost to the forefront.
Moving to Value Based Care – Leveraging advanced analytics to measure physici...LexisNexis Risk Solutions
Payment reform and emphasis on value-based care is forcing payers, ACOs, and Integrated Delivery Networks to look for ways through which physician performance can be evaluated and measured over time with the goal of creating highly efficient and effective physician networks. With more pressure and risk moving to physicians – they will expect fair measurement of quality against their peers. Join this webinar to understand the implications of value-based care as it relates to physician performance analysis and why the ability to effectively monitor physicians with less than acceptable cost performance and those with high-quality performance will be non-negotiable.
Achieving Sustainable Savings in Purchased Services Through Best PracticesModern Healthcare
Purchased-service agreements present an area of potential savings for operational budgets if hospitals have the right data, research and tools to control and reprioritize their purchased-services spending.
Join us as we learn how SSM Health, a four-state non-profit health care system, implemented a best-practices approach to purchased services to secure large-dollar savings across its entire purchased-services spend. During this webinar Cris O'Neal-Gavin, System Contract manager for Purchased Services at SSM Health, will share how they drove savings in large national purchased-services categories, and achieved even larger savings in more strategic regional services. Also get exclusive access to MD Buyline's most recent research showcasing how the nation's most innovative hospitals are implementing common strategies to reduce the cost and complexity of purchased-services contracts.
A Clinically Integrated Network (CIN) is a selective partnership of physicians collaborating with
hospital(s) and other providers to deliver evidence-based care, improve quality and efficiency,
manage populations and demonstrate value to the market. Once these objectives are met, the network may contract on behalf of participants
Navigating Medical Staff Officer and Physician Leadership Compensation MD Ranger, Inc.
Every hospital has a medical staff that functions as an indispensable partner in quality oversight, credentialing, accreditation, and operations. The medical staff elects officers to represent its physicians. Payment for medical staff officers varies by facility and position and can be a complex area to navigate. With healthcare organizations spending more and more on these types of roles, it is important to think strategically about this area of increasing concern.
In this webinar, we will talk about paying physicians in leadership positions reasonably and fairly. Join MD Ranger for this 30-minute webinar as we discuss:
-The (growing) diversity of physician leadership roles
-When to pay
-How much to pay
-Ways to structure payment
On 11th February 2016 the Big Lottery Fund and CBO evaluation team ran a peer learning event for people developing SIBs related to health. These slides are from the workshop on the Ways to Wellness SIB.
2013 10 utilizing member engagement to improve cahps scoresimagine.GO
The Accountable Care Act means more access to healthcare for more people. But to pay for that access it also means margins for healthcare companies are going to be squeezed. But this does not necessarily imply doom for healthcare companies. The law actually encourages healthcare businesses to build better business models – and is willing to pay for it. By retooling your market approach, and the operations that run your business, you can actually improve your margins and your customer’s happiness at the same time you are helping to create a better and more efficient healthcare ecosystem.
Outside/In: Building a Community-Centric Strategic PlanYourCareUniverse
This course will review the benefits of conducting a deep dive into the health and wellness needs of your community and identifying gaps. Leverage insights from this research to: > Drive community wellness > Shape business strategy by leveraging data-driven insights > Facilitate collaboration within your service area > Cultivate a loyal consumer base
North highland himss_hardwiringclinicalfinancialperformance_041315North Highland
North Highland's Ricardo Martinez and Donna Houlne's presentation on "Hardwiring Clinical and Financial Performance Through Patient-Centered, Physician-Directed Transformation"
Edifecs CJR: don't fumble with your bundle ssEdifecs Inc
Comprehensive Care for Joint Replacement (CJR) opens the door to opportunity for improved joint replacement patient care delivery. With full accountability for both cost and quality for the joint replacement episode, hospitals must share critical data in near real time to align and coordinate the full continuum of post-acute providers. The top complexities Jay Sultan addressed include:
The top complexities Jay Sultan addressed include:
Considerations for entering into contracts with your orthopedic surgeons and other collaborating episode providers
Episode bundle administration and monitoring; gain sharing administration
Real-time data acquisition from collaborating providers
Analytics and reporting, focused care delivery management, and preparation for CMS audits
Whatever burning issues and questions are on your mind
Streamlining Your Medical Practice for Profitability and SuccessConventus
Conventus webinar video providing key success strategies and tactics for improving productivity, profitability, and patient care. The one-hour video features host Susan Lieberman of Conventus and Stevie Davidson of Health Informatics Consulting.
You work hard to design marketing and outreach strategies to attract referring physicians and grow referral volume. Learn how you can simplify the referral process to ensure you capture the volume you worked so hard to attain by downloading our white paper: Physician Marketing & Outreach, Omni-Channel Experience.
Key Strategies for Compensating Physician Administrative PositionsMD Ranger, Inc.
Establishing rates for medical directorships has hidden challenges and risks. Even the most sophisticated market data benchmarks should be thoroughly examined and utilized properly. In addition to analyzing market data correctly, there’s an art to establishing rates policies for your organization. This webinar addresses challenges to determining appropriate rates and shares successful organizational policies.
Physician contract compliance can be less of a headache if your organization takes a planned, methodical approach to obtaining and recording payments rates.
If your facility could use best practices for determining and documenting FMV for physician contracts, join us for our 30-minute webinar covering:
--The meaning of FMV
--Various methods to determine FMV
--Strategies for efficient documentation
Pros And Cons Of Payment Models For Internal Medicine Billing.pptxRichard Smith
Internal medicine billing can be a complex and challenging process, and it’s crucial to have a payment model that works for both healthcare providers and payers. In recent years, there have been several different payment models that have emerged in the field of internal medicine billing, each with its own pros and cons.
Similar to Anita Charlesworth: Pay for performance (20)
Evaluation of the Integrated Care and Support Pioneers ProgrammeNuffield Trust
Nick Mays of the Policy Innovation Research Unit presents some conclusions from the early evaluation of the Integrated Care and Support Pioneers Programme.
Effectiveness of the current dominant approach to integrated care in the NHSNuffield Trust
Jonathan Stokes of the Greater Manchester Primary Care Patient Safety Translational Research Centre presents a systematic review of case management in integrated care.
Providing actionable healthcare analytics at scale: Understanding improvement...Nuffield Trust
Thomas Woodcock, Improvement Science Fellow at Imperial College London, talks about the various measurement approaches and processes when working at large scale to assess care quality improvements.
Ramani Moonesinghe, Associate National Clinical Director for Elective Care at NHS England, discusses the use of data for monitoring care quality at various levels within the system.
Paul Aylin, Co-Director of the Dr Foster Unit at Imperial College London, gives concrete examples of using a specific statistical model for monitoring care quality, cumulative sum (CUSUM).
Martin Utley, Director of the Clinical Operational Research Unit at University College London, reflects upon his involvement in the launch of specific tools to monitor care quality for paediatric cardiac surgery.
Evaluating new models of care: Improvement Analytics UnitNuffield Trust
Martin Caunt, Improvement Analytics Unit Project Director and NHS England and Adam Steventon, Director of Data Analytics at The Health Foundation share insights into how they have approached evaluating new models of care.
Lisa Annaly, Head of Provider Analytics at the Care Quality Commission, discusses lessons learned from the CQC as they have worked to monitor care quality over time.
Kate Silvester, a healthcare systems engineer, discusses the challenges of working with data and statistical techniques for real-time monitoring of care quality.
Monitoring quality of care: making the most of dataNuffield Trust
Chris Sherlaw-Johnson, Senior Research Analyst at the Nuffield Trust, introduced the Monitoring quality of care conference and gives an overview of some of the approaches that we've been using at the Trust to identify where care quality has been improving, especially for frail and older people.
Providing actionable healthcare analytics at scale: Insights from the Nationa...Nuffield Trust
Christopher Boulton, Falls and Fragility Fracture Audit Programme Manager at the Royal College of Physicians and Rob Wakeman, Clinical Lead for Orthopaedic Surgery at the National Hip Fracture Database talk about what they have learned by analysing the national hip fracture database.
Providing actionable healthcare analytics at scale: A perspective from stroke...Nuffield Trust
Benjamin Bray, Research Director and the Sentinel Stroke National Audit Programme, presents at the Monitoring quality of care conference about stroke care analytics.
New Models of General Practice: Practical and policy lessonsNuffield Trust
Nuffield Trust policy researchers Rebecca Rosen and Stephanie Kumpunen present findings from our upcoming report on large scale general practice models.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
2. Key Issues 3: Pay for performance
Why pay for performance?
1. Signalling
• payment is one way to signal what is important and
incentivise providers to focus on this?
• Others are targets, regulatory and professional standards
and guidelines?
• Is payment more effective that the other options? Is
payment more effective if it is combined with other levers?
• What is different about payment?
Supported by:
3. Key Issues 3: Pay for performance
2. Quality and cost
• Better quality is more expensive
• Why not just increase reimbursement price to deliver desired quality?
• If performance varies substantially between providers – quality premium or threshold
avoids economic rents.
• Better quality is cheaper
• Why not just reduce the reimbursement price?
• If improved quality reduces activity is this a form of gain sharing to incentivise providers
to make improvements which would have a negative impact on their income?
• Concerned about the instability this might cause for providers and patients who may find
it difficult to achieve quality standard.
Supported by:
4. Key Issues 3: Pay for performance
Key challenges
• Defining high quality
• The type of indicator: What domains of quality, with what
weight
• Who sets the standard and on what basis – what to reward
• Availability of robust metrics which providers can’t game
• Value – how to achieve improvement rather than
displacement
• Administrative cost and complexity
Supported by:
5. Key topic 3: Pay for performance
• What is the role of pay for performance versus the provision
of better information on quality for patients, physicians and
purchasers?
• What are the strengths and weaknesses of pay for
performance – is it different for physician reimbursement
and hospital reimbursement?
• Which policies help to further a beneficial impact of pay for
performance payments?
• What role, if any, should HTA bodies such as NICE have in
pay for performance models?
• What innovations are next?
Supported by:
